Malignant cells themselves, or lymphocytes that infiltrate tumors, can abnormally express a variety of immune checkpoint molecules, including PD-1/PD-L1, LAG-3, TIM3, and TIGIT, which inhibit the activation of antigen-specific T cells and facilitate tumor cell immune escape (104, 105). The gene discussed is LAG3; the disease is neoplasm.